Ambu A/S
CSE:AMBU B

Watchlist Manager
Ambu A/S Logo
Ambu A/S
CSE:AMBU B
Watchlist
Price: 106.15 DKK -0.14% Market Closed
Market Cap: 28.3B DKK
Have any thoughts about
Ambu A/S?
Write Note

Ambu A/S
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ambu A/S
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Ambu A/S
CSE:AMBU B
Cash from Financing Activities
-kr65m
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
GN Store Nord A/S
CSE:GN
Cash from Financing Activities
-kr2.4B
CAGR 3-Years
-13%
CAGR 5-Years
-27%
CAGR 10-Years
-23%
Demant A/S
CSE:DEMANT
Cash from Financing Activities
-kr1.5B
CAGR 3-Years
7%
CAGR 5-Years
-40%
CAGR 10-Years
-18%
V
ViroGates A/S
CSE:VIRO
Cash from Financing Activities
kr13m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ambu A/S
Glance View

Market Cap
28.3B DKK
Industry
Health Care

Ambu A/S, a Danish company rooted in innovation, has carved a niche in the global healthcare sector through its specialized medical devices. Founded in 1937, Ambu started with a simple mission of improving patient care and has stayed true to that vision by continuously advancing their portfolio. The company's journey began with the invention of the resuscitator bag, a revolutionary product that remains a staple in emergency and hospital settings today. Over the years, Ambu has focused strategically on three main segments: Anesthesia, Patient Monitoring & Diagnostics, and Visualisation, each playing a crucial role in the broader healthcare ecosystem. These segments allow Ambu to develop devices that enhance diagnostic procedures, improve safety, and increase efficiency in medical settings, ultimately saving lives and optimizing healthcare delivery. Ambu’s business model capitalizes primarily on innovation-driven sales, with a strong emphasis on disposable medical devices which are gaining popularity due to hygiene concerns and regulatory trends favoring single-use technologies. These products include their flagship single-use endoscopes, marketed under the brand name "Ambu aScope," which significantly reduce the risk of cross-contamination while providing high-quality diagnostic images. The company's revenue model is built on a B2B approach, dealing directly with hospitals, clinics, and other healthcare providers, ensuring a steady flow of sales through long-term contracts and partnerships. Through constant reinvestment into R&D and strategic acquisitions, Ambu sustains its market leadership, driving growth by addressing the evolving needs of the healthcare industry and setting standards in patient care solutions globally.

AMBU B Intrinsic Value
98.93 DKK
Overvaluation 7%
Intrinsic Value
Price

See Also

What is Ambu A/S's Cash from Financing Activities?
Cash from Financing Activities
-65m DKK

Based on the financial report for Sep 30, 2024, Ambu A/S's Cash from Financing Activities amounts to -65m DKK.

What is Ambu A/S's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
21%

Over the last year, the Cash from Financing Activities growth was 71%.

Back to Top